A new study suggests that the engraftment process following a bone marrow transplantation could be improved by enriching the graft with stem cells that express a ligand for e-selectin, a molecule expressed on bone marrow microvascular cells. The engraftment process depends on effective seeding of the recipient's bone marrow with haematopoietic progenitor cells ( The Lancet , Vol 357, No 9272).
We are a voice to you; you have been a support to us. Together we build journalism that is independent, credible and fearless. You can further help us by making a donation. This will mean a lot for our ability to bring you news, perspectives and analysis from the ground so that we can make change together.
Comments are moderated and will be published only after the site moderator’s approval. Please use a genuine email ID and provide your name. Selected comments may also be used in the ‘Letters’ section of the Down To Earth print edition.